about
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistanceFecal Carriage of Staphylococcus aureus in the Hospital and Community Setting: A Systematic ReviewHow can mathematical models advance tuberculosis control in high HIV prevalence settings?The spread of carbapenemase-producing bacteria in Africa: a systematic reviewMolecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: a systematic reviewA Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric TuberculosisImpact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South AfricaRapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisScreening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective studyOutbreak of multi-drug resistant Pseudomonas aeruginosa bloodstream infection in the haematology unit of a South African Academic HospitalImpact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trialVariable host-pathogen compatibility in Mycobacterium tuberculosisFeasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyAcquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma.High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India.Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study.Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected childrenRegulatory T Cells and Pro-inflammatory Responses Predominate in Children with Tuberculosis.Utility of Second-Generation Line Probe Assay (Hain MTBDRplus) Directly on 2-Month Sputum Specimens for Monitoring Tuberculosis Treatment Response.Diagnostic accuracy of Xpert MTB/RIF for extrapulmonary tuberculosis specimens: establishing a laboratory testing algorithm for South AfricaThe Influence of HIV on the Evolution of Mycobacterium tuberculosis.Association between Gc genotype and susceptibility to TB is dependent on vitamin D statusMixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes.Research capacity. Enabling the genomic revolution in Africa.Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adultsDistribution of strain families of Mycobacterium tuberculosis causing pulmonary and extrapulmonary disease in hospitalized children in Cape Town, South Africa.Strains of Mycobacterium tuberculosis from western Maharashtra, India, exhibit a high degree of diversity and strain-specific associations with drug resistance, cavitary disease, and treatment failure.Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study.Modern lineages of Mycobacterium tuberculosis exhibit lineage-specific patterns of growth and cytokine induction in human monocyte-derived macrophages.New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects.Detection of Streptococcus pneumoniae from Different Types of Nasopharyngeal Swabs in Children.Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studiesCytotoxic mediators in paradoxical HIV-tuberculosis immune reconstitution inflammatory syndrome.A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion.Increasing the value of health research in the WHO African Region beyond 2015--reflecting on the past, celebrating the present and building the future: a bibliometric analysisInvestigating the early-life determinants of illness in Africa: the Drakenstein Child Health Study.A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens.Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa.Comparison of a Real-Time Multiplex PCR and Sequetyping Assay for Pneumococcal Serotyping.
P50
Q22241307-87B74389-47DB-45A0-AF42-A473E5C7AE4FQ26744688-E066CFD4-7C61-407C-B9D9-F1DE26DB1A3DQ26824057-9B4250B9-7FDB-4C60-834D-38E979DC3348Q27000635-4DD83612-3F08-4FC2-A2A1-3657C6835DFBQ27006781-C80EC1A0-070F-488C-AE0E-BDA952EA369CQ28082583-9BFEAED9-635B-4108-B95D-63D0A13F550EQ28394564-A1A863EE-B97A-419C-9151-F425BDFE838FQ28477855-6313FB95-D945-4E27-8B37-BEC93427567EQ28479309-791B42BA-9CC7-419B-9FE8-2620BBCE9EAFQ28488031-103915E3-9EE9-497C-AC5A-E1773295E937Q28545155-299F9DDA-1177-4FA0-83AE-43DC9EA5C997Q28768257-B1C88B5F-792C-492A-9A70-B0A8CDEF601CQ29615717-CBBD217C-6A38-490E-B2E1-82EADF18936CQ33222437-01948C06-B5F9-484D-87A1-1B0E99127BF7Q33475938-4B71377D-61F6-468E-AF14-CC5294623512Q33576204-358F1838-746A-401B-9ACA-0372C16479A0Q33589272-A9198534-4FF5-4E55-98B8-5AFD370FF6ABQ33600218-ED93BA38-0E02-4508-9658-3F68C8DF04E0Q33603890-A2EE7DC8-24B6-4C21-99F7-2839C15AE872Q33703605-3EF07727-0224-4F31-8F3A-8DED8ABC2220Q33757201-065D125F-4E06-455E-BB25-F84F45A05CFCQ33828322-75579D6A-7C8C-4C40-A019-871B5022BD5CQ33900005-37A0436C-B23D-4AB9-9989-58AD661F5058Q34068017-0CDA7246-997A-4E50-A50F-1E886BB92994Q34098274-204B7F51-6D60-4734-8F82-01B124964AD3Q34143909-6885CA86-6323-4A27-9087-1E468B81FA0EQ34190244-A123B8AD-2D3F-4171-B465-5E5A7ABA9E1CQ34367051-ADBB008E-2090-4E0E-9245-1FFC7018FF2AQ34391365-5BF7B2E9-BF58-4CF7-8589-E3A563923836Q34644528-E413B249-6EF9-4ADD-8934-AA311AEF1E91Q34808449-AB4EDB33-7824-4DF9-951F-523E8C0B2C1FQ34978276-B1BCBBB3-6172-4C06-8127-D9A435B3B11BQ35056457-99450923-DEB6-4F65-9CD9-82728A658429Q35108344-998A9163-F066-47CD-B725-26F70770A4A8Q35179927-18E7153F-FD82-4E96-98C4-F269FAA8E2E6Q35257290-30CA0511-2AC8-47C0-AA35-82113D2F2277Q35528326-41312E9F-5291-4C23-8405-8F26EA131290Q35530503-B050EA3F-AB09-4383-AFB3-BE22E9AB7752Q35746807-AE306E34-F671-44A4-80EF-BFE50F63318DQ35763468-30D6950E-4DC8-4B10-93FB-310C1887AE46
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mark Nicol
@ast
Mark Nicol
@en
Mark Nicol
@es
Mark Nicol
@nl
Mark Nicol
@sl
type
label
Mark Nicol
@ast
Mark Nicol
@en
Mark Nicol
@es
Mark Nicol
@nl
Mark Nicol
@sl
prefLabel
Mark Nicol
@ast
Mark Nicol
@en
Mark Nicol
@es
Mark Nicol
@nl
Mark Nicol
@sl
P106
P1153
9242829600
P21
P31
P496
0000-0002-1366-4805